chr22-26470757-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_022081.6(HPS4):​c.558G>A​(p.Ser186Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0388 in 1,614,016 control chromosomes in the GnomAD database, including 1,401 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. S186S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.035 ( 105 hom., cov: 33)
Exomes 𝑓: 0.039 ( 1296 hom. )

Consequence

HPS4
NM_022081.6 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -4.59

Publications

6 publications found
Variant links:
Genes affected
HPS4 (HGNC:15844): (HPS4 biogenesis of lysosomal organelles complex 3 subunit 2) This gene encodes a protein component of biogenesis of lysosome-related organelles complexes (BLOC). BLOC complexes are important for the formation of endosomal-lysosomal organelles such as melanosomes and platelet dense granules. Mutations in this gene result in subtype 4 of Hermansky-Pudlak syndrome, a form of albinism. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2012]
HPS4 Gene-Disease associations (from GenCC):
  • Hermansky-Pudlak syndrome 4
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Hermansky-Pudlak syndrome with pulmonary fibrosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP6
Variant 22-26470757-C-T is Benign according to our data. Variant chr22-26470757-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 163675.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-4.59 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0353 (5367/152222) while in subpopulation NFE AF = 0.0411 (2795/67998). AF 95% confidence interval is 0.0398. There are 105 homozygotes in GnomAd4. There are 2525 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 105 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HPS4NM_022081.6 linkc.558G>A p.Ser186Ser synonymous_variant Exon 7 of 14 ENST00000398145.7 NP_071364.4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HPS4ENST00000398145.7 linkc.558G>A p.Ser186Ser synonymous_variant Exon 7 of 14 1 NM_022081.6 ENSP00000381213.2 Q9NQG7-1

Frequencies

GnomAD3 genomes
AF:
0.0353
AC:
5362
AN:
152104
Hom.:
104
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0281
Gnomad AMI
AF:
0.0197
Gnomad AMR
AF:
0.0382
Gnomad ASJ
AF:
0.100
Gnomad EAS
AF:
0.00135
Gnomad SAS
AF:
0.0215
Gnomad FIN
AF:
0.0240
Gnomad MID
AF:
0.0316
Gnomad NFE
AF:
0.0411
Gnomad OTH
AF:
0.0382
GnomAD2 exomes
AF:
0.0325
AC:
8157
AN:
251304
AF XY:
0.0326
show subpopulations
Gnomad AFR exome
AF:
0.0261
Gnomad AMR exome
AF:
0.0215
Gnomad ASJ exome
AF:
0.103
Gnomad EAS exome
AF:
0.000924
Gnomad FIN exome
AF:
0.0229
Gnomad NFE exome
AF:
0.0401
Gnomad OTH exome
AF:
0.0347
GnomAD4 exome
AF:
0.0391
AC:
57218
AN:
1461794
Hom.:
1296
Cov.:
32
AF XY:
0.0385
AC XY:
28022
AN XY:
727206
show subpopulations
African (AFR)
AF:
0.0266
AC:
890
AN:
33478
American (AMR)
AF:
0.0234
AC:
1048
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.105
AC:
2741
AN:
26132
East Asian (EAS)
AF:
0.000730
AC:
29
AN:
39700
South Asian (SAS)
AF:
0.0216
AC:
1864
AN:
86254
European-Finnish (FIN)
AF:
0.0241
AC:
1285
AN:
53406
Middle Eastern (MID)
AF:
0.0238
AC:
137
AN:
5758
European-Non Finnish (NFE)
AF:
0.0422
AC:
46885
AN:
1111960
Other (OTH)
AF:
0.0387
AC:
2339
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
3122
6244
9366
12488
15610
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1784
3568
5352
7136
8920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0353
AC:
5367
AN:
152222
Hom.:
105
Cov.:
33
AF XY:
0.0339
AC XY:
2525
AN XY:
74438
show subpopulations
African (AFR)
AF:
0.0280
AC:
1163
AN:
41536
American (AMR)
AF:
0.0382
AC:
584
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.100
AC:
347
AN:
3468
East Asian (EAS)
AF:
0.00154
AC:
8
AN:
5184
South Asian (SAS)
AF:
0.0220
AC:
106
AN:
4822
European-Finnish (FIN)
AF:
0.0240
AC:
254
AN:
10604
Middle Eastern (MID)
AF:
0.0340
AC:
10
AN:
294
European-Non Finnish (NFE)
AF:
0.0411
AC:
2795
AN:
67998
Other (OTH)
AF:
0.0388
AC:
82
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
272
545
817
1090
1362
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
64
128
192
256
320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0367
Hom.:
157
Bravo
AF:
0.0358
Asia WGS
AF:
0.0140
AC:
47
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 22, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:2
Feb 21, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Ser186Ser in exon 7 of HPS4: This variant is not expected to have clinical signi ficance because it does not alter an amino acid residue and is not located withi n the splice consensus sequence. It has been identified in 4.3% (367/8600) of Eu ropean American chromosomes from a broad population by the NHLBI Exome Sequencin g Project (http://evs.gs.washington.edu/EVS; dbSNP rs13054747). -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hermansky-Pudlak syndrome Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.56
CADD
Benign
1.3
DANN
Benign
0.85
PhyloP100
-4.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13054747; hg19: chr22-26866723; COSMIC: COSV61103177; COSMIC: COSV61103177; API